Time required for indocyanine green fluorescence emission for evaluating bowel perfusion in left-sided colon and rectal cancer surgery
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature..
BACKGROUND: Indocyanine green fluorescence imaging (ICG-FI) has been reported to be useful in reducing the incidence of anastomotic leakage (AL) in colectomy. This study aimed to investigate the correlation between the required time for ICG fluorescence emission and AL in left-sided colon and rectal cancer surgery using the double-stapling technique (DST) anastomosis.
METHODS: This retrospective study included 217 patients with colorectal cancer who underwent left-sided colon and rectal surgery using ICG-FI-based perfusion assessment at our department between November 2018 and July 2022. We recorded the time required to achieve maximum fluorescence emission after ICG systemic injection and assessed its correlation with the occurrence of AL.
RESULTS: Among 217 patients, AL occurred in 21 patients (9.7%). The median time from ICG administration to maximum fluorescence emission was 32 s (range 25-58 s) in the AL group and 28 s (range 10-45 s) in the non-AL group (p < 0.001). The cut-off value for the presence of AL obtained from the ROC curve was 31 s. In 58 patients with a required time for ICG fluorescence of 31 s or longer, the following risk factors for AL were identified: low preoperative albumin [3.4 mg/dl (range 2.6-4.4) vs. 3.9 mg/dl (range 2.6-4.9), p = 0.016], absence of preoperative mechanical bowel preparation (53.8% vs. 91.1%, p = 0.005), obstructive tumor (61.5% vs. 17.8%, p = 0.004), and larger tumor diameter [65 mm (range 40-90) vs. 35 mm (range 4.0-100), p < 0.001].
CONCLUSION: The time required for ICG fluorescence emission was associated with AL.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
|---|---|
| Enthalten in: |
Surgical endoscopy - 37(2023), 10 vom: 28. Okt., Seite 7876-7883 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hagiwara, Chie [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anastomotic leakage |
|---|
| Anmerkungen: |
Date Completed 27.09.2023 Date Revised 06.10.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00464-023-10356-8 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361389507 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361389507 | ||
| 003 | DE-627 | ||
| 005 | 20231226085032.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00464-023-10356-8 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1204.xml |
| 035 | |a (DE-627)NLM361389507 | ||
| 035 | |a (NLM)37640952 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hagiwara, Chie |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Time required for indocyanine green fluorescence emission for evaluating bowel perfusion in left-sided colon and rectal cancer surgery |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 27.09.2023 | ||
| 500 | |a Date Revised 06.10.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. | ||
| 520 | |a BACKGROUND: Indocyanine green fluorescence imaging (ICG-FI) has been reported to be useful in reducing the incidence of anastomotic leakage (AL) in colectomy. This study aimed to investigate the correlation between the required time for ICG fluorescence emission and AL in left-sided colon and rectal cancer surgery using the double-stapling technique (DST) anastomosis | ||
| 520 | |a METHODS: This retrospective study included 217 patients with colorectal cancer who underwent left-sided colon and rectal surgery using ICG-FI-based perfusion assessment at our department between November 2018 and July 2022. We recorded the time required to achieve maximum fluorescence emission after ICG systemic injection and assessed its correlation with the occurrence of AL | ||
| 520 | |a RESULTS: Among 217 patients, AL occurred in 21 patients (9.7%). The median time from ICG administration to maximum fluorescence emission was 32 s (range 25-58 s) in the AL group and 28 s (range 10-45 s) in the non-AL group (p < 0.001). The cut-off value for the presence of AL obtained from the ROC curve was 31 s. In 58 patients with a required time for ICG fluorescence of 31 s or longer, the following risk factors for AL were identified: low preoperative albumin [3.4 mg/dl (range 2.6-4.4) vs. 3.9 mg/dl (range 2.6-4.9), p = 0.016], absence of preoperative mechanical bowel preparation (53.8% vs. 91.1%, p = 0.005), obstructive tumor (61.5% vs. 17.8%, p = 0.004), and larger tumor diameter [65 mm (range 40-90) vs. 35 mm (range 4.0-100), p < 0.001] | ||
| 520 | |a CONCLUSION: The time required for ICG fluorescence emission was associated with AL | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Anastomotic leakage | |
| 650 | 4 | |a Bowel perfusion | |
| 650 | 4 | |a Colorectal cancer | |
| 650 | 4 | |a Double stapling technique | |
| 650 | 4 | |a ICG | |
| 650 | 4 | |a Indocyanine green | |
| 650 | 7 | |a Indocyanine Green |2 NLM | |
| 650 | 7 | |a IX6J1063HV |2 NLM | |
| 650 | 7 | |a Coloring Agents |2 NLM | |
| 700 | 1 | |a Wakabayashi, Taiga |e verfasserin |4 aut | |
| 700 | 1 | |a Tsutsui, Atsuko |e verfasserin |4 aut | |
| 700 | 1 | |a Sakamoto, Junichi |e verfasserin |4 aut | |
| 700 | 1 | |a Fujita, Shohei |e verfasserin |4 aut | |
| 700 | 1 | |a Fujiyama, Yoshiki |e verfasserin |4 aut | |
| 700 | 1 | |a Okamoto, Nobuhiko |e verfasserin |4 aut | |
| 700 | 1 | |a Omura, Kenji |e verfasserin |4 aut | |
| 700 | 1 | |a Naitoh, Takeshi |e verfasserin |4 aut | |
| 700 | 1 | |a Wakabayashi, Go |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Surgical endoscopy |d 1996 |g 37(2023), 10 vom: 28. Okt., Seite 7876-7883 |w (DE-627)NLM012660159 |x 1432-2218 |7 nnns |
| 773 | 1 | 8 | |g volume:37 |g year:2023 |g number:10 |g day:28 |g month:10 |g pages:7876-7883 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00464-023-10356-8 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 37 |j 2023 |e 10 |b 28 |c 10 |h 7876-7883 | ||